Betrnet Stem Cells and the Origins of Barrett's Esophagus Project 3 RF Ablation
NCT01568723 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 125
Last updated 2021-12-15
Summary
The purpose of this study is to determine biomarkers which can predict response to ablation therapy in patients with Barretts esophagus.
Conditions
- Barrett's Esophagus
Interventions
- GENETIC
-
response to therapy
evaluate specific markers for response to therapy at specific intervals pre and post therapy
Sponsors & Collaborators
-
National Cancer Institute (NCI)
collaborator NIH - lead OTHER
Principal Investigators
-
Kenneth K Wang, MD · Mayo Clinic
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-01-31
- Primary Completion
- 2018-08-16
- Completion
- 2018-08-16
Countries
- United States
Study Locations
More Related Trials
-
Comparison of Treatments for Barrett's Esophagus With High-Grade Dysplasia/Early Adenocarcinoma
NCT01961778 ·Status: COMPLETED ·Phase: NA
-
Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry
NCT00574327 ·Status: RECRUITING
-
Barrett's Esophagus Patient Registry
NCT01776346 ·Status: UNKNOWN
-
A Study of Barrett's Esophagus Patients to Investigate Quality of Life and Fear of Cancer, and Optimize a Risk Model Based on Biomarkers and New Technologies to Better Predict the Development of Cancer
NCT06523374 ·Status: RECRUITING ·Phase: NA
-
A Minimally-Invasive Sponge on a String Device for Screening for Barrett's Esophagus
NCT02560623 ·Status: COMPLETED ·Phase: NA
-
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
NCT03961945 ·Status: RECRUITING ·Phase: NA
-
The Use of Biomarkers to Guide Management of Patients Treated With Radiofrequency Ablation for Early Oesophageal Neoplasia
NCT04155242 ·Status: RECRUITING ·Phase: NA
-
Preliminary Longitudinal Validation of Biomarkers Predictive of Barrett's Esophagus
NCT00844077 ·Status: COMPLETED
-
Evaluation of MicroRNA Expression in Blood and Cytology for Detecting Barrett's Esophagus and Associated Neoplasia
NCT02464930 ·Status: UNKNOWN
-
The Microenvironment in Barrett's Esophagus
NCT03060642 ·Status: COMPLETED
-
Tamoxifen to Treat Barrett's Metaplasia
NCT02089386 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Cryotherapy -BEATS-RF Ablation Trial
NCT01882478 ·Status: COMPLETED
-
The Study of Barrett's Esophagus: What Are the Factors of Progression
NCT00586404 ·Status: TERMINATED
-
Endoscopic Resection or Ablation for Patients With Dysplasia or Cancer Requiring Treatment of Barrett's Esophagus
NCT01572987 ·Status: TERMINATED ·Phase: NA
-
Evaluation of Balloon-based Cryoablation of Human Esophageal Epithelium
NCT01293448 ·Status: COMPLETED ·Phase: NA
-
Endoscopic Therapy of Early Cancer in Barretts Esophagus
NCT00217087 ·Status: COMPLETED ·Phase: PHASE2
-
The Microbiome, Bile Acids, and Notch in Barrett's Esophagus (BE)
NCT05524844 ·Status: COMPLETED
-
The Effects of Sorafenib on Molecular Barrett's Esophagus Cancer
NCT00619242 ·Status: TERMINATED ·Phase: NA
-
Epidemiology of Barrett's Esophagus: A Population Based Study
NCT01286155 ·Status: COMPLETED
-
Erlotinib in Treating Patients With Barrett Esophagus
NCT00566800 ·Status: UNKNOWN ·Phase: PHASE1
-
Racial Disparity in Barrett's Esophagus
NCT01374074 ·Status: COMPLETED
-
Utility Of Mutational Load As A Predictor For Endoscopic Treatment Response In Barrett's Esophagus
NCT04316975 ·Status: COMPLETED ·Phase: NA
-
Metabolomic and BH3 Profiling of Esophageal Cancers: Identification of Novel Assessment Methods of Treatment Response for Precision Therapy
NCT03223662 ·Status: TERMINATED ·Phase: PHASE2
-
Enhancing Screening Practices for BE
NCT07335445 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Endoscopic Radiofrequency Ablation Versus Hybrid Argon Plasma Coagulation in the Treatment of Barrett's Esophagus
NCT05051475 ·Status: COMPLETED ·Phase: NA